Connect Biopharma (CNTB) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free CNTB Stock Alerts $1.96 +0.32 (+19.51%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 4, 2024 | americanbankingnews.comConnect Biopharma (NASDAQ:CNTB) Trading Down 5%May 22, 2024 | globenewswire.comConnect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe AsthmaMay 11, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest UpdateConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large drop in short interest in the month of April. As of April 30th, there was short interest totalling 31,200 shares, a drop of 62.5% from the April 15th total of 83,100 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 159,800 shares, the short-interest ratio is currently 0.2 days.May 7, 2024 | globenewswire.comConnect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe AsthmaApril 26, 2024 | finance.yahoo.comConnect Biopharma Holdings Limited (CNTB)April 24, 2024 | marketbeat.comBML Capital Management LLC Makes New $2.43 Million Investment in Connect Biopharma Holdings Limited (NASDAQ:CNTB)BML Capital Management LLC acquired a new position in Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,061,438 shares of the company's stoApril 19, 2024 | marketbeat.comHC Wainwright Analysts Lift Earnings Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Equities researchers at HC Wainwright boosted their FY2024 earnings estimates for shares of Connect Biopharma in a note issued to investors on Wednesday, April 17th. HC Wainwright analyst E. Bodnar now anticipates that the company wApril 17, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Given New $8.00 Price Target at HC WainwrightHC Wainwright raised their price target on Connect Biopharma from $7.00 to $8.00 and gave the company a "buy" rating in a research report on Wednesday.April 17, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)April 17, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 7.5% in MarchConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 115,500 shares, a growth of 7.5% from the March 15th total of 107,400 shares. Approximately 0.2% of the company's shares are short sold. Based on an average daily volume of 158,600 shares, the short-interest ratio is presently 0.7 days.April 16, 2024 | globenewswire.comConnect Biopharma Reports Full Year 2023 Financial Results and Provides Business UpdateApril 12, 2024 | marketbeat.comFY2025 EPS Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB) Lifted by Leerink PartnrsConnect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Analysts at Leerink Partnrs boosted their FY2025 earnings per share estimates for Connect Biopharma in a research note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst T. Smith now forecasts that the company will pApril 11, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Connect Biopharma Holdings Amid Promising Clinical Trials and Strategic PartnershipsApril 7, 2024 | marketwatch.comADRs Advance; Connect Biopharma Climbs 19%April 1, 2024 | marketwatch.comADRs End Higher; Connect Biopharma Climbs 26%March 30, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 13.2% in MarchConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 107,400 shares, a decline of 13.2% from the February 29th total of 123,700 shares. Approximately 0.2% of the company's stock are sold short. Based on an average daily trading volume, of 133,300 shares, the days-to-cover ratio is currently 0.8 days.March 19, 2024 | tmcnet.comConnect Biopharma to Participate in H.C. Wainwright 2n? Annual Autoimmune & Inflammatory Disease Virtual ConferenceMarch 19, 2024 | globenewswire.comConnect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual ConferenceMarch 6, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Connect Biopharma Holdings Limited's FY2023 Earnings (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - HC Wainwright issued their FY2023 earnings estimates for shares of Connect Biopharma in a note issued to investors on Monday, March 4th. HC Wainwright analyst E. Bodnar forecasts that the company will earn ($0.70) per share for theMarch 5, 2024 | msn.comHC Wainwright & Co. Initiates Coverage of Connect Biopharma Holdings Limited - Depositary Receipt () (CNTB) with Buy RecommendationMarch 4, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright began coverage on shares of Connect Biopharma in a report on Monday. They set a "buy" rating and a $7.00 price target for the company.February 22, 2024 | benzinga.comConnect Biopharma Hldgs Stock (NASDAQ:CNTB) Dividends: History, Yield and DatesFebruary 12, 2024 | finance.yahoo.comConnect Biopharma Appoints Industry Veteran James Huang to Board of DirectorsFebruary 8, 2024 | marketbeat.comFY2024 EPS Estimates for Connect Biopharma Holdings Limited Lowered by Analyst (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for Connect Biopharma in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will post eFebruary 7, 2024 | marketbeat.comLeerink Partnrs Comments on Connect Biopharma Holdings Limited's FY2028 Earnings (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Stock analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for Connect Biopharma in a report released on Monday, February 5th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.44) perFebruary 3, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Trading 4% Higher Connect Biopharma (NASDAQ:CNTB) Shares Up 4%January 29, 2024 | finance.yahoo.comWill Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?December 15, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Connect Biopharma Holdings (CNTB) and Inspire Medical Systems (INSP)December 15, 2023 | seekingalpha.comCNTB Connect Biopharma Holdings LimitedDecember 12, 2023 | morningstar.comConnect Biopharma Holdings Ltd ADR CNTBDecember 12, 2023 | marketwatch.comConnect Biopharma Shares Jump on Positive Results for Asthma Treatment TrialDecember 12, 2023 | msn.comConnect Biopharma gains as asthma candidate succeeds in mid-stage trialDecember 12, 2023 | finance.yahoo.comConnect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent AsthmaDecember 11, 2023 | finance.yahoo.comConnect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023November 30, 2023 | finance.yahoo.comStonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus ManagementNovember 28, 2023 | finance.yahoo.comIs Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?November 21, 2023 | msn.comWhy Is Skin Disease-Focused Connect Biopharma Stock Lower Today?November 21, 2023 | msn.comConnect Biopharma stock rises on positive data from dermatitis mAbNovember 21, 2023 | finance.yahoo.comConnect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic DermatitisNovember 21, 2023 | finance.yahoo.comConnect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater ChinaNovember 20, 2023 | finance.yahoo.comConnect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023November 9, 2023 | finance.yahoo.comConnect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 41% ownership, insiders own 22%November 6, 2023 | finance.yahoo.comIs Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?November 1, 2023 | msn.comConnect Biopharma Holdings Ltd - ADR (CNTB) Price Target Increased by 16.67% to 7.14October 30, 2023 | marketbeat.comTrading was temporarily halted for "CNTB" at 09:10 AM with a stated reason of "LULD pause."October 20, 2023 | finance.yahoo.comHas Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?September 15, 2023 | finance.yahoo.comConnect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?September 15, 2023 | seekingalpha.comConnect Biopharma GAAP EPS of -RMB 3.90September 14, 2023 | finanznachrichten.deConnect Biopharma Holdings Limited: Connect Biopharma Reports First Half 2023 Financial Results and Provides Business UpdateSeptember 12, 2023 | finanznachrichten.deConnect Biopharma Holdings Limited: Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight! TRY "INVESTING IDEAS" TODAY CNTB Media Mentions By Week CNTB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTB News Sentiment▼0.000.75▲Average Medical News Sentiment CNTB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTB Articles This Week▼11▲CNTB Articles Average Week Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RAPT News Today ZVRA News Today LXRX News Today KRRO News Today TBPH News Today ERAS News Today PGEN News Today VRCA News Today ORGO News Today VNDA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTB) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored